{"url_path":"/sec/lmed/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 EXHIBITS**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-20","source_url":"https://www.sec.gov/Archives/edgar/data/1477960/0001477932-26-003348-index.html","accession_number":"0001477932-26-003348","cik":"0001477960","ticker":"LMED","issuer_name":"LataMed AI Corp.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1477960/0001477932-26-003348-index.html","primary_entity_key":"0001477960","primary_entity_name":"LataMed AI Corp."},"word_count":411,"has_tables":true,"body_markdown":"**ITEM 6 - EXHIBITS**\n\n**Number Description of Exhibit**\n\n \n\n[3.1](http://www.sec.gov/Archives/edgar/data/1477960/000147793224000547/cbbb_ex31.htm)\n\n \n\n[Articles of Incorporation, as amended (1)](http://www.sec.gov/Archives/edgar/data/1477960/000147793224000547/cbbb_ex31.htm)\n\n[3.2](http://www.sec.gov/Archives/edgar/data/1477960/000147793224004973/cbbb_ex31.htm)\n\n \n\n[Certificate of Amendment to the Articles of Incorporation of LataMed AI Corp.(2)](http://www.sec.gov/Archives/edgar/data/1477960/000147793224004973/cbbb_ex31.htm)\n\n[3.3](http://www.sec.gov/Archives/edgar/data/1477960/000147793224004973/cbbb_ex32.htm)\n\n \n\n[Certificate of Change Reflecting Reverse Stock Split(2)](http://www.sec.gov/Archives/edgar/data/1477960/000147793224004973/cbbb_ex32.htm)\n\n[3.4](http://www.sec.gov/Archives/edgar/data/1477960/000147793224000547/cbbb_ex32.htm)\n\n \n\n[Bylaws(1)](http://www.sec.gov/Archives/edgar/data/1477960/000147793224000547/cbbb_ex32.htm)\n\n[31.1](cctc_ex311.htm)\n\n \n\n[Certification of Principal Executive Officer Pursuant to Rule 13A-14(A) Under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.**](cctc_ex311.htm)\n\n[31.2](cctc_ex312.htm)\n\n \n\n[Certification of Principal Financial and Accounting Officer Pursuant to Rule 13A-14(A) Under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.**](cctc_ex312.htm)\n\n[32.1](cctc_ex321.htm)\n\n \n\n[Certification pursuant to Securities Exchange Act of 1934 Rule 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002. **](cctc_ex321.htm)\n\n[32.2](cctc_ex322.htm)\n\n \n\n[Certification pursuant to Securities Exchange Act of 1934 Rule 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002. **](cctc_ex322.htm)\n\n101.INS\n\n \n\nInline XBRL Instance Document\n\n101.SCH\n\n \n\nInline XBRL Taxonomy Extension Schema\n\n101.CAL\n\n \n\nInline XBRL Taxonomy Extension Calculation Linkbase\n\n101.DEF\n\n \n\nInline XBRL Inline XBRL Taxonomy Extension Definition Linkbase\n\n101.LAB\n\n \n\nInline XBRL Inline XBRL Taxonomy Extension Labels Linkbase\n\n101.PRE\n\n \n\nInline XBRL Taxonomy Extension Presentation Linkbase\n\n104\n\n \n\nCover Page Interactive Data File (Embedded within the Inline XBRL document)\n\n \n\n \n\n*(1)*\n\n*Filed with the SEC on February 5, 2024 as an exhibit to our Registration Statement on Form 10-12G*\n\n \n\n*(2)*\n\n*Filed with the SEC on August 16, 2024 as an exhibit to Current Report on Form 8-K*\n\n \n\n****\n\n*Filed herewith*\n\n \n\n*# The XBRL related information in Exhibit 101 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section and shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.*\n\n \n\n \n\n18\n\n*Table of Contents*\n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.\n\n \n\n \n\n**LataMed AI Corp.**\n\n \n\n \n\n \n\n \n\n \n\nDate: May 20, 2026\n\nBy:\n\n*/s/ Kevin Rodan Levy*\n\n \n\n \n\nName:\n\nKevin Rodan Levy\n\n \n\n \n\nTitle:\n\nChief Executive Officer (Principal Executive Officer)\n\n \n\n \n\nDate: May 20, 2026\n\nBy:\n\n*/s/ Carlos Pena*\n\n \n\n \n\nName:\n\nCarlos Pena\n\n \n\n \n\nTitle:\n\nChief Financial Officer (Principal Financial and Accounting Officer)\n\n \n\n \n\n \n\n19"}